These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9147616

  • 21. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.
    Odoux C, Albers A, Amoscato AA, Lotze MT, Wong MK.
    Int J Cancer; 2002 Feb 01; 97(4):458-65. PubMed ID: 11802207
    [Abstract] [Full Text] [Related]

  • 22. Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines.
    Gagandeep S, Novikoff PM, Ott M, Gupta S.
    Cancer Lett; 1999 Feb 08; 136(1):109-18. PubMed ID: 10211948
    [Abstract] [Full Text] [Related]

  • 23. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN.
    Cancer Res; 2001 Jan 15; 61(2):759-63. PubMed ID: 11212279
    [Abstract] [Full Text] [Related]

  • 24. Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells.
    Griffin D, Wittmann S, Guo F, Nimmanapalli R, Bali P, Wang HG, Bhalla K.
    Gynecol Oncol; 2003 Apr 15; 89(1):37-47. PubMed ID: 12694652
    [Abstract] [Full Text] [Related]

  • 25. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
    Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR, Tortora G.
    Clin Cancer Res; 2000 May 15; 6(5):2053-63. PubMed ID: 10815932
    [Abstract] [Full Text] [Related]

  • 26. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages.
    Kirikae T, Ojima I, Ma Z, Kirikae F, Hirai Y, Nakano M.
    Biochem Biophys Res Commun; 1998 Apr 28; 245(3):698-704. PubMed ID: 9588177
    [Abstract] [Full Text] [Related]

  • 27. Synergistic interaction between cyclophosphamide or paclitaxel and the bioreductive compound NLCPQ-1, in vivo.
    Papadopoulou MV, Ji M, Bloomer WD.
    Oncol Res; 2003 Apr 28; 13(12):561-6. PubMed ID: 12899246
    [Abstract] [Full Text] [Related]

  • 28. Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo.
    Milross CG, Peters LJ, Hunter NR, Mason KA, Milas L.
    Int J Cancer; 1995 Sep 04; 62(5):599-604. PubMed ID: 7665232
    [Abstract] [Full Text] [Related]

  • 29. Impact of tolerance on antitumor efficacy of tumor necrosis factor in mice.
    Fraker DL, Sheppard BC, Norton JA.
    Cancer Res; 1990 Apr 15; 50(8):2261-7. PubMed ID: 2317813
    [Abstract] [Full Text] [Related]

  • 30. Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors.
    Nishiguchi I, Willingham V, Milas L.
    Int J Radiat Oncol Biol Phys; 1990 Mar 15; 18(3):555-8. PubMed ID: 2318687
    [Abstract] [Full Text] [Related]

  • 31. Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel.
    Tedjarati S, Baker CH, Apte S, Huang S, Wolf JK, Killion JJ, Fidler IJ.
    Clin Cancer Res; 2002 Jul 15; 8(7):2413-22. PubMed ID: 12114447
    [Abstract] [Full Text] [Related]

  • 32. Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude mice.
    Lin LW, Lin XD, He YM, Gao SD, Xue ES.
    World J Gastroenterol; 2003 Apr 15; 9(4):701-5. PubMed ID: 12679914
    [Abstract] [Full Text] [Related]

  • 33. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
    Erba PA, Manfredi C, Lazzeri E, Minichilli F, Pauwels EK, Sbrana A, Strauss HW, Mariani G.
    J Nucl Med; 2010 May 15; 51(5):775-81. PubMed ID: 20395330
    [Abstract] [Full Text] [Related]

  • 34. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X, Mo R, Ding Y, Zheng W, Zhang C.
    Mol Pharm; 2014 Jan 06; 11(1):145-57. PubMed ID: 24261922
    [Abstract] [Full Text] [Related]

  • 35. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
    Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, Peters LJ.
    Cancer Res; 1995 Aug 15; 55(16):3564-8. PubMed ID: 7627965
    [Abstract] [Full Text] [Related]

  • 36. 130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
    Wiedenmann N, Valdecanas D, Hunter N, Hyde S, Buchholz TA, Milas L, Mason KA.
    Clin Cancer Res; 2007 Mar 15; 13(6):1868-74. PubMed ID: 17363543
    [Abstract] [Full Text] [Related]

  • 37. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo.
    Shi B, Yaremko B, Hajian G, Terracina G, Bishop WR, Liu M, Nielsen LL.
    Cancer Chemother Pharmacol; 2000 Mar 15; 46(5):387-93. PubMed ID: 11127943
    [Abstract] [Full Text] [Related]

  • 38. Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma.
    Yen WC, Prudente RY, Lamph WW.
    Breast Cancer Res Treat; 2004 Nov 15; 88(2):141-8. PubMed ID: 15564797
    [Abstract] [Full Text] [Related]

  • 39. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
    Chun E, Lee KY.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):771-9. PubMed ID: 14975768
    [Abstract] [Full Text] [Related]

  • 40. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
    Fujimoto S, Chikazawa H.
    Jpn J Cancer Res; 1998 Dec 12; 89(12):1343-51. PubMed ID: 10081496
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.